High-fat diet and intrauterine growth retardation may predispose to obesity, insulin resistance, and type 2 diabetes. Because prenatal ethanol (ETOH) exposure causes intrauterine growth retardation, we investigated its interactions with postnatal high-fat diet on glucose tolerance and adipocytederived hormones in the rat offspring.
T HE NATURAL HISTORY of type 2 diabetes is charac-
terized by a period of insulin resistance, with euglycemia and compensatory hyperinsulinemia, followed by a period of impaired glucose tolerance during which insulin secretion becomes altered, leading to overt diabetes when insulin secretion is inadequate (1) . Genetic, congenital, and environmental factors are thought to determine the development of insulin resistance and its worsening, which results in glucose intolerance and diabetes. Though several genes encoding enzymes of insulin action have been identified, they do not seem to play a major role in the pathogenesis of diabetes in the majority of patients (2) . Among environmental determinants of insulin resistance, the role of diets high in saturated fat has been extensively studied. High-fat diets, which characteristically are consumed in modern Western societies, adversely affect glucose metabolism by decreasing the sensitivity of glucose transport to insulin. These diets induce insulin resistance by increasing body fat accretion, promoting skeletal muscle triglycerides synthesis, and augmenting circulating free fatty acids (FFAs; Ref. 3) . High-fat diets also cause liver insulin resistance, evident by an impaired ability of insulin to suppress hepatic glucose production (4) .
The importance of congenital or gestational factors was first recognized by epidemiological studies describing associations between intrauterine growth retardation (IUGR) and insulin resistance, impaired glucose tolerance, type 2 diabetes, and cardiovascular diseases later in life (5) . Other studies have found associations between intrauterine exposure to the diabetic milieu and obesity, insulin resistance, and glucose intolerance in the offspring (6) . Similar results have been reported in regards to prenatal exposure to famine, which causes IUGR (7) . Animal models of IUGR [including placental ischemia (8) , glucocorticoid exposure (9) , and global or protein malnutrition (10 -12) during pregnancy] agree with these epidemiological studies; and it is now generally believed that adverse events during pregnancy may interfere with fetal physiology, metabolism, and development and may program the fetus to later develop metabolic diseases in adulthood (13) .
Ethanol (ETOH) ingestion during pregnancy can lead to abnormal fetal development, sometimes manifested as the fetal alcohol syndrome (FAS) (14) . IUGR is a hallmark of FAS, and the prevalence of FAS is elevated in populations with lower socioeconomic status (15) , where type 2 diabetes is also common (16) . A few studies in humans (17) and rodents (18, 19) have reported the presence of glucose intolerance in offspring exposed to ETOH in utero. It has been suggested that ETOH-induced IUGR is associated with insulin resistance, but its pathogenesis remains unclear. In a recent study, glucose uptake was decreased in red muscle of offspring of rats exposed to ETOH in vitro, but insulin receptor tyrosine kinase activity was not altered (20) .
Recent reports suggest that adipocytokines may be involved in the control of energy homeostasis and insulin action. Congenital or acquired lipoatrophy is associated with insulin resistance, which can be reduced by adipose tissue transplantation or by leptin, a product of the ob gene secreted by the adipocyte (21). Leptin also inhibits food intake, reduces body weight, stimulates energy expenditure, and decreases hyperglycemia and hyperinsulinemia in leptin-defi-cient, ob/ob mice (21, 22). Adiponectin, another adipocyte protein also known as ACRP30 or adipoQ, has been proposed to be an important link between obesity and type 2 diabetes. The expression and circulating levels of adiponectin are reduced in obese rodents, monkeys, and humans and increased by weight loss and thiazolidinediones (21, 23-25). Circulating adiponectin levels are inversely related with fasting insulin concentrations and positively correlated with insulin sensitivity, determined by euglycemic clamps in humans and monkeys (26, 27). In addition, elevation in circulating adiponectin levels inhibited endogenous glucose production and reduced glycemia in mice (28 -30).
Resistin, a more recently identified adipocyte hormone, has also been proposed to link obesity to type 2 diabetes (31). Resistin was elevated in obese diabetic mice, and its administration or neutralization resulted in impaired or improved insulin action, respectively. In a recent report, we have shown that prenatal ETOH exposure results in IUGR, with impaired glucose homeostasis and increased resistin expression, in newborn and adult offspring (32). The adult offspring had glucose intolerance, hyperinsulinemia, and reduced skeletal muscle glucose transporter (GLUT)4 expression, but there were no alterations of adipose tissue mass, leptin, or leptin receptor expression. The present study was undertaken to determine the interaction of prenatal ETOH exposure with postnatal high-fat diet on glucose tolerance and the expression of adipocytokines in rats.
Materials and Methods Materials
Mouse adiponectin and rat insulin and leptin RIA kits were from Linco Research, Inc. (St. Charles, MO). Resistin enzyme immunoassay kit was from Phoenix Pharmaceuticals, Inc. (Belmont, CA). FFA assay kit (NEFA C) was from Wako Pure Chemical Industries Ltd. (Richmond, VA). Anti-GLUT4 antibody was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-uncoupling protein (UCP)-3 antibody was from Chemicon International (Temecula, CA). Electrophoresis reagents were purchased from Bio-Rad Laboratories, Inc. (Hercules, CA). ECL enhanced chemiluminescence kit was obtained from Amersham Pharmacia Biotech (Piscataway, NJ). Trizol, SuperScript reverse transcriptase, Taq DNA polymerase, and oligo(deoxythymidine) primers were obtained from Life Technologies, Inc. (Rockville, MD). cDNA primers were synthesized by Life Technologies, Inc. Insulin immunohistochemistry kit was from DAKO Corp. Diagnostics (Mississauga, Ontario, Canada). The high-fat diet (D12451) was purchased from Research Diets (New Brunswick, NJ). ETOH to be administered to rats was obtained from pharmaceutical services of the Health Sciences Centre (Winnipeg, Manitoba, Canada). Isopropyl alcohol and methanol were from Fisher Scientific (Nepean, Ontario, Canada). All other chemicals were purchased from Sigma-Aldrich Corp. (Oakville, Ontario, Canada).
Animals and experimental design
Virgin Sprague Dawley rats were purchased from Charles River Laboratories, Inc. (Saint Constant, Quebec, Canada) and housed in individual cages under controlled temperature, humidity, and light cycle. They were allowed free access to tap water and commercial rat chow (Agway Prolab, Syracuse, NY), providing a balanced amount of minerals and vitamins and containing 20% proteins, 11% fat, and 69% carbohydrates. The rats were randomly divided into two weightmatched groups, and pregnancy was timed using the vaginal sperm plug. Throughout gestation, one group was given ETOH, 2 g/kg (36%) by gavage twice daily at 0900 and 1600 h, and the second group (control) was given the same volume of water instead of ETOH. Body weight and food intake were recorded from d 14 of gestation to parturition. Rat offspring were weaned onto either normal chow or high-fat diet providing 45% calories as fat, 35% carbohydrates, and 20% proteins. For body weight and food studies, the rats were housed 1 d per week in individual plastic cages with metal wire basket tops. Food was weighed and placed on the basket top. After 24 h, remaining food was weighed, and food intake was calculated as the difference between the two weights, corrected for any food spill, assessed by scanning the cage bedding. Body weights were recorded at the same time. At 13 wk of age, the rats were fasted overnight and underwent an ip glucose tolerance test (IPGTT) by 0900 h the next morning. Glucose (30% wt/vol), 2 g/kg body weight, was injected ip; and tail blood (40 l) was collected at 0, 30, 60, and 120 min for glucose determination. The rats were killed by exsanguination, through cardiac puncture under light ether anesthesia, and gastrocnemius muscle was stored at -70 C until used. Another set of rats were killed without prior overnight fast; and gastrocnemius muscle, pancreas, and epididymal adipose tissues were obtained. Aliquots of serum were stored at -20 C until assayed. The protocol was approved by the Committee for Animal Use in Research and Teaching of the University of Manitoba.
Adiponectin and resistin expression
Total RNA was extracted from approximately 100 mg adipose tissue, by the Trizol method (Life Technologies, Inc.). The first-strand cDNAs for resistin and adiponectin were synthesized from 5 g total RNA, using SuperScript reverse transcriptase and oligo(deoxythymidine) primers. The reverse transcription products (5 l) were amplified by PCR, using Taq DNA polymerase and specific primers for adiponectin (sense: 5Ј-GTTCTCTTCACCTACGACCAG-3Ј; antisense: 5Ј-GGAA-GAGAAGAAAGCCAGTAA-3) and resistin (sense: 5Ј-TTTTCCTTT-TCTTCCTTGTCC-3Ј; antisense: 5Ј-TGCTGTCCAGTCTATCCTTGC-3Ј). Another 5 l of the reverse transcription product was amplified with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers as an internal control. The amplification conditions for both PCRs were 94 C for 45 sec, 55 C for 45 sec, and 72 C for 90 sec (30 cycles). The expected RT-PCR products of resistin and adiponectin are 267 and 178 bp in length, respectively. RT-PCR products (10 l) were electrophoresed in a 1.5% agarose gel, stained with ethidium bromide, and densitometrically analyzed using NIH Image software.
GLUT-4 content
Gastrocnemius muscle tissue (500 mg) was homogenized for 5 sec using a Brinkmann Instruments, Inc. (Westbury, NY) homogenizer in ice-cold TES buffer [20 mm Tris-HCl (pH 7.4), containing 250 mm sucrose, 1 mm EDTA, 1 mm phenylmethylsulfonylfluoride, 0.01 mm leupeptin, and 5 g/ml aprotinin]. The homogenate was spun twice at 3,000 ϫ g for 10 min at 4 C, the supernatant spun again at 100,000 ϫ g for 90 min at 4 C, and the resultant precipitate suspended in ice-cold TES by shearing using 22-, 25-, and 30-gauge needles. Protein (50 g per lane) was separated on a 12% sodium dodecyl sulfate-polyacrylamide gel and electroblotted onto nitrocellulose membranes. Blots were blocked with 5% dry milk for 1 h and incubated with rabbit anti-GLUT4 antiserum at 1:1,000 dilution for 1 h at room temperature. Blots were then washed in Tris-buffered saline (TBS)-Tween for 15 min, incubated with goat antirabbit horseradish peroxidase-conjugated secondary antibody at 1:3,000 for 1 h at room temperature, and washed in TBS-Tween for 15 min. Immune complexes were detected using the ECL chemiluminescent detection kit, after exposing the blots to an Eastman Kodak Co. (Rochester, NY) Biomax Light Film. GLUT4 protein was quantified by densitometry using NIH Image software.
Uncoupling protein-3 content
Gastrocnemius muscle tissue was homogenized using a Brinkmann Instruments, Inc. homogenizer in a solution of 10 mm Tris-HCl buffer (pH 7.4), containing 250 mm sucrose and 1 mm EDTA. Mitochondrial fractions were then prepared as described by Cannon and Lindberg (33). Briefly, the homogenate was centrifuged at 12,000 ϫ g for 30 min. The pellet was resuspended in the same buffer and was centrifuged at 800 ϫ g for 10 min. After saving the supernatant, the nuclear pellet was resuspended and centrifuged as above. Both supernatants were combined and centrifuged at 10,000 ϫ g for 30 min. The mitochondrial pellet was resuspended in the same buffer. Protein (50 g per lane) was separated on a 12% sodium dodecyl sulfate-polyacrylamide gel and electroblotted onto nitrocellulose membranes. Blots were blocked with 5% dry milk for 1 h and incubated overnight at 4 C with anti-UCP-3 antibody at 1:800 dilution. Blots were then washed in TBS-Tween for 15 min, incubated with goat antirabbit horseradish peroxidase-conjugated secondary antibody at 1:20,000 for 1 h at room temperature, and washed in TBSTween for 15 min. Immune complexes were detected using the ECL chemiluminescent detection kit as described above.
Pancreatic insulin content
Pancreases were dissected and immediately frozen at -70 C. Proteins were extracted using the acid-ETOH method (34). Briefly, pancreases weighing 350 -450 mg were homogenized in 5 ml acid-ETOH buffer (1.5 ml HCl, 12 m in 100 ml 70% ETOH) and incubated overnight at 4 C for further extraction. On the next day, samples were centrifuged at 3000 ϫ g for 15 min at 4 C, and supernatants were stored at -70 C for assay. Insulin content was measured with a rat insulin RIA kit.
Pancreatic histomorphometry
The whole pancreas was dissected out, weighed, and fixed in 10% buffered formaldehyde solution. The tissue was dehydrated and embedded in paraffin, and 6-m sections were stained with hematoxylin and eosin by standard procedures. Paraffin-embedded sections were also immunostained using the DAKO Corp. Envisionϩ system according to the manufacturer's recommendations. Sections were first deparaffinized with xylene and rehydrated with ETOH and distilled water. Sections were next incubated with a rabbit antiinsulin Igs (1:100), followed by peroxidase-labeled polymer conjugated to goat antirabbit Igs. Sections were then stained with 3,3Ј-diaminobenzidine substrate-chromogen, counterstained with hematoxylin and eosin, and examined by light microscopy for islet counting. Morphometric analysis was performed using a light microscope connected to a Microprojection System and Northern Exposure software (Nikon, Hollywood, CA). The relative cross-sectional area of ␤-cells was determined by marking the threshold of the captured image for brown tissue (␤-cells) and for blue tissue (exocrine pancreas). These analyses were performed by three individuals, two of whom were blinded to the study. Total tissue area was corrected for the unstained area. ␤-Cell density was calculated as the cross-sectional area of ␤-cells per tissue section area. ␤-Cell mass per pancreatic piece was estimated as the product of ␤-cell density and the weight of the fresh pancreatic piece, and total ␤-cell mass per animal was estimated from the fresh weight of the pancreas.
Other assays
Serum insulin and leptin were measured with rat-specific RIA kits (Linco Research, Inc.). Serum adiponectin was measured with a mouse RIA kit (Linco Research, Inc.), which (according to the manufacturer) has a high cross-reactivity with rat adiponectin. Serial dilutions of rat serum in our laboratory produced values that paralleled the standard curve. Serum resistin was determined by enzyme immunoassay (Phoenix Pharmaceuticals, Inc.), with an antibody raised against the human resistin (51-108)-NH 2 , which (according to the manufacturer) recognizes rat resistin. Values we obtained with serial dilutions of rat serum paralleled the standard curve in this assay. Glucose was measured using a 2300 glucose analyzer (YSI, Inc., Yellow Springs, OH). Tissue protein was determined by the Bradford method, using BSA as standard.
Statistics
All analyses were conducted with SPSS, Inc. software (version 10.1 for Windows; SPSS, Inc., Chicago, IL). Differences between two groups were evaluated by unpaired t test. Individual glucose and insulin measurements during IPGTT were compared by repeated-measures ANOVA. Effects of prenatal ETOH exposure and postnatal high-fat diet were analyzed by two-way ANOVA using ETOH and fat diet as fixed factors. Insulin values were log-transformed before analysis. Values are expressed as the mean Ϯ sem. P Ͻ 0.05 was considered significant.
Results

Animal weight and food intake
The amount of ETOH ingested (ϳ1.5 g/d) provided approximately 7 kcal/g body weight or approximately 10.5 kcal/d; and ETOH dams consumed 19.6 Ϯ 0.9 g chow per day, providing 68.6 Ϯ 3.2 kcal daily. The total daily caloric intake (ϳ79.0 kcal) was not significantly different than that of control dams, whose daily chow consumption was 24.
At birth, ETOH pups weighed significantly less than controls (5.1 Ϯ 0.1 vs. 6.3 Ϯ 0.1 g, P Ͻ 0.001), and weight difference persisted until 6 wk of age. Weight of ETOH rats then caught up to control weight, and rats from both groups weaned onto normal chow subsequently had comparable weights (Fig. 1A) . Weaning onto a high-fat diet resulted in more weight gain in both groups, with, however, a slower weight gain in offspring of ETOH dams. Postnatal diet (P Ͻ 0.001), but not prenatal ETOH (P ϭ 0.139), was a significant determinant of weight at 13 wk of age, and there was a significant interaction between diet and prenatal ETOH exposure (P Ͻ 0.025). The weight of epididymal fat pads was higher in rats fed a high-fat diet, compared with those on normal chow, but ETOH offspring on a high-fat diet tended to have larger epididymal fat than controls (Table 1) . Food intake was significantly lower in ETOH offspring, compared with controls, at 4 wk of age; but it reached control level by 5 wk and subsequently increased, with age, similarly in both groups until 8 wk and then plateaued (Fig. 1B) . Daily food ingestion was quantitatively greater in rats weaned onto normal chow than in those on high-fat diet, regardless of prenatal conditions, but caloric intakes were similar except for being reduced in high-fat-fed ETOH offspring after 8 wk of age (Fig. 1C) .
Adipose hormones, FFA, and UCP-3
Because of difference in adiposity and food intake between dietary groups, we measured serum leptin and resistin and determined adipose tissue resistin mRNA and skeletal muscle UCP-3. Serum leptin concentration was higher in highfat-fed rats than in those on normal chow; and among the high-fat diet groups, there was a tendency for elevated leptin in ETOH offspring, compared with controls ( Fig. 2A) . Similar to leptin, skeletal muscle UCP-3 was elevated in rats fed a high-fat diet, compared with those on normal chow (Fig. 2B) . Adipose tissue resistin mRNA and serum resistin concentration were significantly elevated in ETOH offspring, compared with controls, but were not affected by high-fat diet (Fig. 3) . We also determined serum adiponectin, adipose tissue adiponectin mRNA, and serum FFA. Serum adiponectin levels were normal in all groups (Fig. 4A) . A significant reduction in adipose tissue adiponectin mRNA was found only in non-ETOH-exposed high-fat-fed rats (Fig. 4B) . ETOH had no effect on serum FFA level, but there was a surprisingly significant effect of high-fat diet to decrease FFA (Table 1) .
Glucose tolerance, insulin, and GLUT4
To study the interaction between prenatal ETOH exposure and postnatal diet on glucose homeostasis, we measured serum glucose and insulin levels in the nonfasting state and during an IPGTT after an overnight fast. The fasting and nonfasting glucose levels were similar among all four groups. Both nonfasting (Table 1 ) and fasting insulin levels were elevated in the ETOH offspring, compared with controls, and increased further on high-fat diet. During IPGTT, glucose levels increased most in ETOH offspring on high-fat diet, and intermediate increases were found in chow-fed ETOH rats and in high-fat-fed controls, which showed comparable glucose values (Fig. 5A) . The area under the glucose curve correlated with glycemic increases. Insulin response peak to ip glucose challenge and the area under the insulin curve were greatest in high-fat-fed ETOH offspring and smallest in controls, with intermediate values in high-fat-fed controls and chow-fed ETOH rats (Fig. 5B) .
Because glucose intolerance in association with hyperinsulinemia suggests the presence of insulin resistance, we measured GLUT4 in skeletal muscle membranes (Fig. 6 ). In the random-fed state, GLUT4 level was not different among groups, despite differences in circulating insulin levels. After glucose challenge, GLUT4 was significantly lower in highfat-fed normal rats and in chow-fed ETOH rats, compared with controls, and tended to further decrease in high-fat-fed ETOH animals.
Pancreas morphometry and insulin content
Because changes in insulin levels could be caused by ␤-cell changes, we measured pancreatic insulin content and performed histomorphometric analyses of pancreatic islets (Table 2). The pancreas was significantly larger in the two groups of rats fed high-fat diet, compared with those on normal chow, and the islet density was higher in the three study groups, compared with controls. Pancreatic insulin content, ␤-cell density, and ␤-cell mass significantly increased in high-fat-fed normal rats, but this increase was offset in high-fat-fed ETOH rats.
Discussion
We have recently shown that alcohol ingestion by the mother during pregnancy results in IUGR with impaired glucose homeostasis and increased resistin expression in newborn and adult offspring. The adult offspring had glucose intolerance, hyperinsulinemia, and reduced skeletal muscle GLUT4 expression. These manifestations of insulin resistance were not associated with alterations of adipose tissue mass, leptin, or leptin receptor expression (32). In the current study, we have extended these investigations and now report on the effects of a postnatal high-fat diet on weight and glucose regulation in the offspring of dams ingesting ETOH during pregnancy. We show that high-fat diet worsens glucose intolerance and decreases adiponectin mRNA, but has no effect on resistin expression, above the level achieved with in utero ETOH exposure. In addition, prenatal ETOH exposure did not alter adiponectin expression in these animals.
High-fat diet caused less weight gain in offspring of ETOH dams, which also had less caloric intake, compared with controls. However, even though consuming less calories, these ETOH offspring had the largest epididymal fat pads and gained more weight than controls and chow fed ETOH rats, indicating that the high-fat diet increased energy storage in ETOH offspring through appetite-independent mechanisms. Leptin and UCP-3 increased equally with high-fat feeding in both ETOH and control offspring, probably reflecting protective mechanisms against further weight gain (35, 36).
High-fat diet reduced GLUT4 expression, increased insulin secretion, and worsened glucose tolerance (37, 38). Glucose transport across the plasma membrane is the ratelimiting step for glucose metabolism in skeletal muscle, and the insulin-dependent glucose transporter GLUT4 is a primary determinant of insulin-stimulated glucose uptake and metabolism in this tissue. Increasing muscle GLUT4 content by transgenic overexpression or by increased contractile activity enhances insulin-stimulated muscle glucose uptake, whereas reducing the content of GLUT4 by gene knockout, denervation, or aging impairs insulin-mediated muscle glucose uptake (39) . The decreased skeletal muscle GLUT4 content in ETOH offspring on chow or high-fat diet, therefore, provides a mechanism for insulin resistance in these animals.
FIG. 2.
Serum leptin and gastrocnemius muscle UCP-3 protein in rat offspring at 13 wk of age. ETOH effect on leptin (P ϭ 0.09) and UCP-3 (P ϭ NS). HIFA effect on both leptin and UCP-3 (P Ͻ 0.001). Data are shown as the mean Ϯ SEM (n ϭ 6 rats/group). O.D, Optical density (arbitrary units).
FIG. 3.
Serum resistin (n ϭ 6 rats/group) (A) and epididymal fat resistin mRNA expression (n ϭ 3 rats/group) (B) in rat offspring at 13 wk of age. Resistin mRNA was measured by RT-PCR (representative blot shown) and expressed in arbitrary units relative to GAPDH mRNA levels (graph shown). ETOH effect, P Ͻ 0.005; HIFA effect, P ϭ NS. Data are shown as the mean Ϯ SEM.
Compared with the high-fat diet alone, the combination of ETOH and high-fat diet decreased pancreatic insulin content while increasing circulating insulin levels. This is a sign of early ␤-cell failure, with insufficient insulin synthesis or storage, but exaggerated insulin secretion to maintain normoglycemia in the presence of insulin resistance (40, 41) .
Because adipocyte factors have been implicated in the regulation of insulin action, we examined FFA, adiponectin, and resistin levels in rat offspring. FFAs are well known to cause insulin resistance of both skeletal muscle and liver, where they interfere with insulin signaling (4, 42) . However, high-fat diet, in this study, was not associated with increases in circulating FFA. This paradoxical observation has been reported before (43) and attributed to an increased efficiency of FFA clearance by skeletal muscle (44) . We found no elevation of FFA in rat offspring exposed to ETOH in utero. Of note, FFA levels in this study were measured after an overnight fast; and it has been suggested that, because of their variability, fasting FFA levels often fail to correlate with manifestations of insulin resistance (45) .
Adiponectin has been implicated as a factor that can mediate FFA lowering, and recent evidence suggests a major role for this protein in the regulation of insulin action (21). Adiponectin expression is reduced in insulin-resistant states, increased with caloric restriction and thiazolidinedione treatment (21, 24, 25), and correlates with insulin sensitivity determined by euglycemic clamps (26, 27). In addition, adiponectin administration increases insulin sensitivity and reduces glycemia in mice (28 -30). In the current study, we found decreased adiponectin expression by high-fat diet in rats, in agreement with the above reports. However, circulating adiponectin levels were normal. A lack of correlation between adiponectin protein and adiponectin mRNA or insulin sensitivity has been reported by others (26). In addition, we found no effect of prenatal ETOH exposure on adiponectin expression, despite glucose intolerance and hyperinsulinemia, suggesting that these abnormalities are not explained by changes in adiponectin levels. We found elevated resistin mRNA and protein in rats after prenatal ETOH exposure but not solely after high-fat diet.
Steppan et al. (31) found elevated resistin levels in both genetic (ob/ob and db/db) and diet-induced obese diabetic   FIG. 4 . Serum adiponectin (A) and epididymal fat adiponectin mRNA (B) in rat offspring at 13 wk of age. Adiponectin mRNA (representative blot shown) was measured by RT-PCR and expressed in arbitrary units relative to GAPDH mRNA levels (graph shown). ETOH and HIFA effects on serum adiponectin, P ϭ NS; ETOH effect on mRNA, P ϭ NS; HIFA effect on mRNA, P ϭ 0.014. Data are shown as the mean Ϯ SEM (n ϭ 6 rats/group).
mice. These authors proposed that resistin is a link between obesity and type 2 diabetes. In their study, antiresistin antibody improved blood glucose and insulin sensitivity in mice with diet-induced obesity, whereas administration of recombinant resistin impaired insulin action in vivo in mice and ex vivo in adipocytes. In addition, circulating resistin levels and adipocyte resistin gene expression were markedly decreased by treatment with the insulin sensitizer, antidiabetic drug rosiglitazone. Subsequent reports have confirmed (46, 47) or questioned (48 -50) the conclusion that resistin levels are elevated in obese insulin-resistant states. Recent genomic studies have shown that noncoding single nucleotide polymorphisms in the resistin gene are associated with obesity (51) or may influence insulin sensitivity in interaction with obesity (52) . In line with these reports, our current results and those of a recent study (32) support a role for resistin in the glucose intolerance associated with ETOHinduced IUGR.
The regulation of adiponectin and resistin levels is not yet well understood. Both hormones are inhibited by ␤-adrenergic agonists (53, 54) , cAMP activators (21, 54), and TNF-␣ (21, 53, 54), which can cause insulin resistance. In addition, an increase in the expression of both adipocytokines has been observed during high-fat feeding in rats (55) . However, these hormones are usually regulated in opposite directions by diet-induced obesity and glucocorticoids, which down-regulate adiponectin (21, 25, 54) and up-regulate resistin (31, 48, 53, 56) . Conversely, thiazolidinediones stimulate adiponectin (21, 24) but inhibit resistin expression (31, 53, 56) . An elevated cortisone level in ETOH-exposed offspring (57) could explain increased resistin but not normal adiponectin expression in these animals. Insulin has been reported to stimulate adiponectin secretion (58) , but its effects on resistin expression have been variable (53, 56, 59) . We have recently shown increased resistin expression in hypoinsulinemic newborn rats exposed to ETOH during pregnancy, suggesting that hyperinsulinemia is an unlikely factor in the increased resistin expression in ETOH offspring (32). Elevated serum glucose concentrations in these pups may have contributed to an increase in resistin expression at this early age (53, 59) . It is uncertain, however, whether this explains the persistently elevated resistin levels during adulthood. Thus, the regulation of both adiponectin and resistin involves multiple hormonal and nutritional factors, and the reason why prenatal ETOH exposure and postnatal highfat diet have differential effects on these hormones is presently unclear. FIG. 6. Gastrocnemius muscle GLUT4 in rat offspring at 13 wk of age. This figure shows representative GLUT4 immunoblots and densitometric analyses of the blots carried out after an IPGTT (n ϭ 6 rats/group). ETOH effect, P ϭ 0.03; HIFA effect, P Ͻ 0.001. Data are shown as the mean Ϯ SEM.
In summary, prenatal ETOH exposure elevated resistin expression, whereas postnatal high-fat diet reduced adiponectin expression in rats. In the presence of both conditions, adiponectin was normal, whereas resistin remained elevated. Both conditions resulted in glucose intolerance and hyperinsulinemia with additive effects. 
